Takeda Pharmaceutical
TAK
#491
Rank
HK$368.15 B
Marketcap
HK$110.63
Share price
0.28%
Change (1 day)
5.89%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): HK$16.06 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.52 Billion. In 2024 the company made an earning of HK$17.36 Billion a decrease over its 2023 earnings that were of HK$17.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$16.06 B-7.49%
2024 HK$17.36 B-2.41%
2023 HK$17.79 B-28.14%
2022 HK$24.75 B-40.9%
2021 HK$41.88 B78.24%
2020 HK$23.50 B246.1%
2019 HK$6.79 B-48.79%
2018 HK$13.25 B-23.64%
2017 HK$17.36 B21.7%
2016 HK$14.26 B-253.01%
2015 -HK$9.33 Billion-159.65%
2014 HK$15.63 B13%
2013 HK$13.83 B2.46%
2012 HK$13.50 B-57.05%
2011 HK$31.43 B-10.49%
2010 HK$35.11 B-3.99%
2009 HK$36.57 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$252.04 B 1,481.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$70.80 B 344.15%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$92.20 B 478.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.74 B 701.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-HK$6.16 Billion-138.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$7.14 B-55.15%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
HK$64.13 B 302.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.53 B 355.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$179.64 B 1,026.95%๐Ÿ‡บ๐Ÿ‡ธ USA